Ducentis Biotherapeutics started in year 2014 as Private Limited Company with registration number 09307415. The Ducentis Biotherapeutics company has been functioning successfully for 10 years now and its status is active. The firm's office is based in 10 Temple Back at Suite 2 First Floor. Postal code: BS1 6FL. Since Monday 6th July 2015 Ducentis Biotherapeutics Ltd. is no longer carrying the name Tripos Biopharma.
The company has 4 directors, namely Jessica R., Masaru M. and Patrick B. and others. Of them, Patrick B., Matthew M. have been with the company the longest, being appointed on 9 September 2022 and Jessica R. and Masaru M. have been with the company for the least time - from 6 December 2023. Currently there are several former directors listed by the company. In addition, the company lists several former secretaries. The full list of both former directors and former secretaries might be found in the box below.
| Office Address | Suite 2 First Floor |
| Town | 10 Temple Back |
| Post code | BS1 6FL |
| Country of origin | United Kingdom |
| Registration Number | 09307415 |
| Date of Incorporation | Wed, 12th Nov 2014 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st December |
| Company age | 10 years old |
| Account next due date | Mon, 30th Sep 2024 (160 days left) |
| Account last made up date | Mon, 31st Oct 2022 |
| Next confirmation statement due date | Sat, 9th Mar 2024 (2024-03-09) |
| Last confirmation statement dated | Fri, 24th Feb 2023 |
Position: Director
Appointed: 06 December 2023
Position: Director
Appointed: 06 December 2023
Position: Director
Appointed: 09 September 2022
Position: Director
Appointed: 09 September 2022
The register of persons with significant control who own or control the company is made up of 4 names. As we discovered, there is Arcutis Biotherapeutics, Inc. from Wilmington, United States. This PSC is categorised as "a delaware corporation", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares. The second one in the persons with significant control register is Lifearc that entered London, United Kingdom as the address. This PSC has a legal form of "a charitable company", owns 25-50% shares. This PSC owns 25-50% shares. The third one is Philip H., who also meets the Companies House criteria to be indexed as a person with significant control. This PSC has significiant influence or control over the company,.
Arcutis Biotherapeutics, Inc.
3411 Silverside Road 3411 Silverside Road, Tatnall Building #104, Wilmington, Delaware, PO Box 19810, United States
| Legal authority | Delaware Law |
| Legal form | Delaware Corporation |
| Notified on | 9 September 2022 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Lifearc
Lynton House 7-12 Tavistock Square, London, WC1H 9LT, United Kingdom
| Legal authority | England And Wales |
| Legal form | Charitable Company |
| Country registered | United Kingdom |
| Place registered | Charity Commission For England And Wales |
| Registration number | 1015243 |
| Notified on | 6 August 2019 |
| Ceased on | 9 September 2022 |
| Nature of control: |
25-50% shares |
Philip H.
| Notified on | 6 April 2016 |
| Ceased on | 9 September 2022 |
| Nature of control: |
significiant influence or control |
David H.
| Notified on | 14 June 2019 |
| Ceased on | 28 April 2021 |
| Nature of control: |
25-50% voting rights 25-50% shares |
| Tripos Biopharma | July 6, 2015 |
| Ducentis Biotherapeutics | May 8, 2015 |
| Deucentis | November 17, 2014 |
| Profit & Loss | ||||||||
|---|---|---|---|---|---|---|---|---|
| Accounts Information Date | 2015-11-30 | 2016-11-30 | 2017-11-30 | 2018-11-30 | 2019-11-30 | 2020-11-30 | 2021-10-31 | 2022-10-31 |
| Net Worth | 11 036 | 4 240 | ||||||
| Balance Sheet | ||||||||
| Cash Bank On Hand | 5 725 | 387 952 | 30 848 | 1 760 714 | 559 027 | 624 323 | 26 990 | |
| Current Assets | 11 036 | 5 925 | 45 800 | 1 791 651 | 894 258 | 965 140 | 28 604 | |
| Debtors | 1 160 | 201 | 24 094 | 14 952 | 30 937 | 335 231 | 340 817 | 1 614 |
| Net Assets Liabilities | 745 535 | -657 424 | -752 424 | |||||
| Other Debtors | 14 952 | 30 937 | 60 605 | 8 561 | 1 614 | |||
| Property Plant Equipment | 1 333 | 961 | 620 | |||||
| Cash Bank In Hand | 9 876 | 5 725 | ||||||
| Net Assets Liabilities Including Pension Asset Liability | 11 036 | 4 240 | ||||||
| Reserves/Capital | ||||||||
| Called Up Share Capital | 136 | 158 | ||||||
| Profit Loss Account Reserve | -39 064 | -85 860 | ||||||
| Shareholder Funds | 11 036 | 4 240 | ||||||
| Other | ||||||||
| Accumulated Depreciation Impairment Property Plant Equipment | 156 | 528 | 869 | |||||
| Average Number Employees During Period | 6 | 6 | 6 | 2 | ||||
| Bank Borrowings Overdrafts | 3 449 | |||||||
| Convertible Bonds In Issue | 1 331 100 | |||||||
| Corporation Tax Recoverable | 274 626 | 332 256 | ||||||
| Creditors | 1 686 | 4 474 | 30 509 | 160 352 | 149 684 | 1 331 100 | 781 028 | |
| Increase From Depreciation Charge For Year Property Plant Equipment | 156 | 372 | 341 | 372 | ||||
| Issue Equity Instruments | 2 024 046 | 60 000 | 3 111 316 | |||||
| Net Current Assets Liabilities | 11 036 | 4 240 | 407 572 | 15 291 | 1 631 299 | 744 574 | 673 056 | -752 424 |
| Other Creditors | 30 509 | 112 800 | 61 344 | 258 347 | 775 262 | |||
| Other Disposals Decrease In Depreciation Impairment Property Plant Equipment | 1 241 | |||||||
| Other Disposals Property Plant Equipment | 1 489 | |||||||
| Other Taxation Social Security Payable | 18 608 | 1 944 | 1 466 | |||||
| Profit Loss | -437 594 | -406 705 | -947 097 | -1 402 959 | -3 206 316 | |||
| Property Plant Equipment Gross Cost | 1 489 | 1 489 | 1 489 | |||||
| Total Additions Including From Business Combinations Property Plant Equipment | 1 489 | |||||||
| Total Assets Less Current Liabilities | 11 036 | 4 240 | 407 572 | 15 291 | 1 632 632 | 745 535 | 673 676 | -752 424 |
| Trade Creditors Trade Payables | 28 944 | 86 396 | 28 822 | 5 766 | ||||
| Creditors Due Within One Year Total Current Liabilities | 0 | 1 685 | ||||||
| Number Shares Allotted | 3 758 577 | 3 871 861 | ||||||
| Par Value Share | 0 | 0 | ||||||
| Share Premium Account | 49 964 | 89 942 | ||||||
| Type | Category | Free download | |
|---|---|---|---|
| AP01 |
New director appointment on Wednesday 6th December 2023. filed on: 21st, December 2023 |
officers | Free Download (2 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy